Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CCDC8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
DYRK1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC728099 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
UBR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UQCRC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GTDC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BCL11A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GNA11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DCAF11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MTFP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PART1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CENPB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRMT61A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COL3A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPS27A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DMRT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VEGFB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on